Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Debt / NOTE 1.500% 3/1
-
Market price (% of par)
-
169.06%
-
Total 13F principal
-
$540,259,922
-
Principal change
-
+$13,491,258
-
Total reported market value
-
$912,708,701
-
Number of holders
-
58
-
Value change
-
+$39,020,994
-
Number of buys
-
22
-
Number of sells
-
38
Institutional Holders of SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 as of Q1 2014
As of 31 Mar 2014 SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1 had 58 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $540,259,922 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Citadel Advisors LLC, CALAMOS ADVISORS LLC, Invesco Ltd., MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, SYMPHONY ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, BAKER BROS. ADVISORS LP, BANK OF AMERICA CORP /DE/, and Polar Securities Inc..
This table shows 58 bond principal holders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.